Literature DB >> 14706929

Expression of NGF, Trka and p75 in human cartilage.

A Gigante1, C Bevilacqua, A Pagnotta, S Manzotti, A Toesca, F Greco.   

Abstract

Nerve growth factor (NGF) exerts its action through two types of receptor: high-affinity tyrosine kinase A receptor (trkA) and low-affinity p75 receptor. NGF has a neurotrophic role in central and peripheral nervous system development, but there is also clear evidence of its involvement in the developing skeleton. The aim of the present immunohistochemical study was to investigate the expression and distribution of NGF, trkA, and p75 in normal cartilaginous tissues from adult subjects: articular and meniscal cartilage of the knee, cartilage from the epiglottis, and intervertebral disc tissue. Detection of NGF mRNA was also performed by in situ hybridization. Immunoreaction for NGF and the two receptors in articular chondrocytes, chondrocyte-like cells of meniscus and annulus fibrosus, and chondrocytes of the epiglottis demonstrated that they are all expressed in hyaline, fibrous and elastic cartilaginous tissues, suggesting that they could be involved in cartilage physio-pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14706929

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  15 in total

Review 1.  Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain?

Authors:  José García-Cosamalón; Miguel E del Valle; Marta G Calavia; Olivia García-Suárez; Alfonso López-Muñiz; Jesús Otero; José A Vega
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

2.  A tale of two TrkA inhibitor trials: same target, divergent results.

Authors:  D A Walsh; T Neogi
Journal:  Osteoarthritis Cartilage       Date:  2019-07-26       Impact factor: 6.576

Review 3.  Biological treatment strategies for disc degeneration: potentials and shortcomings.

Authors:  Günther Paesold; Andreas G Nerlich; Norbert Boos
Journal:  Eur Spine J       Date:  2006-09-16       Impact factor: 3.134

Review 4.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

5.  Acid-sensing ion channel 2 (asic 2) and trkb interrelationships within the intervertebral disc.

Authors:  Antonio Cuesta; Eliseo Viña; Roberto Cabo; Gorka Vázquez; Ramón Cobo; Olivia García-Suárez; José García-Cosamalón; José A Vega
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Rac1 mediates load-driven attenuation of mRNA expression of nerve growth factor beta in cartilage and chondrocytes.

Authors:  J W Shim; K Hamamura; A Chen; Q Wan; S Na; H Yokota
Journal:  J Musculoskelet Neuronal Interact       Date:  2013-09       Impact factor: 2.041

7.  Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment.

Authors:  Sture Forsgren; Ola Grimsholm; Tore Dalén; Solbritt Rantapää-Dahlqvist
Journal:  Int J Inflam       Date:  2011-06-08

8.  Anti-nerve growth factor does not change physical activity in normal young or aging mice but does increase activity in mice with skeletal pain.

Authors:  Lisa A Majuta; Stefanie A T Mitchell; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

9.  Genome-wide analysis of pain-, nerve- and neurotrophin -related gene expression in the degenerating human annulus.

Authors:  Helen E Gruber; Gretchen L Hoelscher; Jane A Ingram; Edward N Hanley
Journal:  Mol Pain       Date:  2012-09-10       Impact factor: 3.395

10.  Brain-derived neurotrophic factor and its receptor in the human and the sand rat intervertebral disc.

Authors:  Helen E Gruber; Jane A Ingram; Gretchen Hoelscher; Natalia Zinchenko; H James Norton; Edward N Hanley
Journal:  Arthritis Res Ther       Date:  2008-07-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.